IL6 and myeloid sarcoma: MS is associated with increased circulating levels of proinflammatory cytokines such as interleukin-6 (IL-6) and decreased anti-inflammatory factors such as adiponectin, which are both able to influence insulin sensitivity and endothelial dysfunction (4,5).